Expertise in
16
conditions

Dr. Steven M. Powell

Gastroenterology
UVA Health Digestive Health At Primary Care Center
1221 Lee St, 
Charlottesville, VA 
Accepting New Patients
Offers Telehealth
Expertise in
16
conditions
UVA Health Digestive Health At Primary Care Center
1221 Lee St, 
Charlottesville, VA 

Overview

Steven Powell is a Gastroenterologist practicing medicine in Charlottesville, Virginia.

Dr. Powell is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Gastroesophageal Reflux Disease (GERD), Familial Adenomatous Polyposis, DICER1 Syndrome, Endoscopy, and Colonoscopy.

He is actively involved in clinical research, co-authoring 18 peer reviewed articles and participating in 7 clinical trials. Dr. Powell is currently accepting new patients.

Specialties

Gastroenterology

Licenses

Internal Medicine in VA

Hospital Affiliations

University Of Virginia Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthKeepers
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Piedmont
  • HMO
  • POS
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

UVA Health Digestive Health at Primary Care Center
1221 Lee St, Charlottesville, VA 22903

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Phase 2 Single Arm Trial of Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase 2 Single Arm Trial of Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Drug, Biological
Study Drugs: Nab-Paclitaxel, Cisplatin, Carboplatin, Cetuximab
Study Phase: Phase 2
Phase 2 Trial of Voyager VI (Vesicular Stomatitis Virus Expressing NIS and Human Interferon Beta, VV1), in Combination With Cemiplimab in Patients With Select Solid Tumors
Phase 2 Trial of Voyager VI (Vesicular Stomatitis Virus Expressing NIS and Human Interferon Beta, VV1), in Combination With Cemiplimab in Patients With Select Solid Tumors
Enrollment Status: Active_not_recruiting
Publish Date: July 08, 2026
Intervention Type: Biological
Study Drugs: VV1, Cemiplimab
Study Phase: Phase 2
Phase II Non-Randomized Three Arm Trial of Induction Chemotherapy With Nab-Paclitaxel and Cisplatin (AP: Arms 1 and 3) or Single Agent Nab-paclitaxel (A: Arm 2) as Induction Therapy Followed by Definitive Concurrent Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC): The APA Trial.
Phase II Non-Randomized Three Arm Trial of Induction Chemotherapy With Nab-Paclitaxel and Cisplatin (AP: Arms 1 and 3) or Single Agent Nab-paclitaxel (A: Arm 2) as Induction Therapy Followed by Definitive Concurrent Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC): The APA Trial.
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug, Radiation, Biological
Study Drugs: Nab-Paclitaxel, Cisplatin, Cetuximab
Study Phase: Phase 2
Validation of a Novel Clinical Prediction Scoring System for Improved Bowel Preparation Prior to Outpatient Colonoscopy
Validation of a Novel Clinical Prediction Scoring System for Improved Bowel Preparation Prior to Outpatient Colonoscopy
Enrollment Status: Withdrawn
Publish Date: December 12, 2024
Intervention Type: Other
Study Phase: Not Applicable
A Phase 1 Study of SGN-CD228A in Select Advanced Solid Tumors
A Phase 1 Study of SGN-CD228A in Select Advanced Solid Tumors
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Drug
Study Drug: SGN-CD228A
Study Phase: Phase 1
A Phase 2 Randomized, Multicenter, Double-Blind Study of the Glutaminase Inhibitor Telaglenastat With Pembrolizumab and Chemotherapy Versus Placebo With Pembrolizumab and Chemotherapy in First-Line, Metastatic KEAP1/NRF2-Mutated, Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)
A Phase 2 Randomized, Multicenter, Double-Blind Study of the Glutaminase Inhibitor Telaglenastat With Pembrolizumab and Chemotherapy Versus Placebo With Pembrolizumab and Chemotherapy in First-Line, Metastatic KEAP1/NRF2-Mutated, Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Terminated
Publish Date: September 21, 2022
Intervention Type: Drug, Dietary supplement, Biological
Study Drugs: Telaglenastat, Carboplatin Chemotherapy, Pemetrexed Chemotherapy, Pembrolizumab Immunotherapy, Dexamethasone
Study Phase: Phase 2
Phase 1 Trial of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and Human Interferon Beta (VSV-IFNβ-NIS) Monotherapy and in Combination With Avelumab, in Patients With Refractory Solid Tumors
Phase 1 Trial of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and Human Interferon Beta (VSV-IFNβ-NIS) Monotherapy and in Combination With Avelumab, in Patients With Refractory Solid Tumors
Enrollment Status: Completed
Publish Date: April 27, 2022
Intervention Type: Biological
Study Phase: Phase 1
View 6 Less Clinical Trials

18 Total Publications

Bite-on-Bite Near Miss: From Hemangioma to Gastrointestinal Stromal Tumors.
Bite-on-Bite Near Miss: From Hemangioma to Gastrointestinal Stromal Tumors.
Journal: ACG case reports journal
Published: April 16, 2026
Similar Doctors
Expertise in
27
conditions
Dr. Stephen H. Caldwell
Gastroenterology
Expertise in
27
conditions
Dr. Stephen H. Caldwell
Gastroenterology
Referral may be required

UVA Health Digestive Health Center

1215 Lee St, 
Charlottesville, VA 
 (0.1 miles away)
434-243-3090
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Stephen Caldwell is a Gastroenterologist practicing medicine in Charlottesville, Virginia. Dr. Caldwell is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH), Non-Alcoholic Fatty Liver Disease, Cirrhosis, Liver Transplant, and Endoscopy. Dr. Caldwell is currently accepting new patients.

Expertise in
30
conditions
Dr. Andrew Y. Wang
Gastroenterology
Expertise in
30
conditions
Dr. Andrew Y. Wang
Gastroenterology
Referral may be required

UVA Health Digestive Health Center

1215 Lee St, 
Charlottesville, VA 
 (0.1 miles away)
434-243-3090
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Andrew Wang is a Gastroenterologist practicing medicine in Charlottesville, Virginia. Dr. Wang is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Achalasia, Chronic Pancreatitis, Hereditary Pancreatitis, Endoscopy, and Gastrectomy. Dr. Wang is currently accepting new patients.

Expertise in
22
conditions
Dr. Nicolas M. Intagliata
Gastroenterology
Expertise in
22
conditions
Dr. Nicolas M. Intagliata
Gastroenterology
Referral may be required

UVA Health Digestive Health Center

1215 Lee St, 
Charlottesville, VA 
 (0.1 miles away)
434-243-3090
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Nicolas Intagliata is a Gastroenterologist practicing medicine in Charlottesville, Virginia. Dr. Intagliata is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Liver Failure, Cirrhosis, Spontaneous Bacterial Peritonitis, Liver Transplant, and Endoscopy. Dr. Intagliata is currently accepting new patients.

Frequently Asked Questions about Dr. Steven M. Powell

How do I make an appointment with Dr. Steven M. Powell?

You can book an appointment with Dr. Steven M. Powell by calling their office at 434-243-3090. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Steven M. Powell a top-rated expert for Gastroesophageal Reflux Disease (GERD)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Steven M. Powell is classified as an Advanced expert for Gastroesophageal Reflux Disease (GERD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Steven M. Powell specialize in?

While Dr. Steven M. Powell is a Gastroenterology, they have specific expertise in Gastroesophageal Reflux Disease (GERD), Familial Adenomatous Polyposis, and DICER1 Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Steven M. Powell participate in research or clinical trials?

Yes. Dr. Steven M. Powell has published 18 articles and abstracts on conditions like Gastroesophageal Reflux Disease (GERD). You can view a list of Dr. Steven M. Powell's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Steven M. Powell accept my insurance?

Dr. Steven M. Powell accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 434-243-3090 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Powell's expertise for a condition
ConditionClose
      View All 16 Advanced Conditions
      View All 59 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile